Development and evaluation of novel lipid polymer hybrid nanocarrier system for targeted delivery of HPPH and olaparib for effective triple negative breast cancer treatment

Abstract

newline

Description

Keywords

Citation

Collections

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced